TickerFactsScreenerDevelopers

ADIAL PHARMACEUTICALS, INC. (ADIL) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2017: -$494.9K2018: -$2.50M2019: -$6.34M2020: -$7.63M2021: -$11.95M2022: -$11.19M2023: -$6.81M2024: -$6.92M2025: -$6.49M-$6.49M
2017Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$6.49M+6.2%
2024-$6.92M-1.7%
2023-$6.81M+39.1%
2022-$11.19M+6.4%
2021-$11.95M-56.5%
2020-$7.63M-20.4%
2019-$6.34M-153.7%
2018-$2.50M-404.9%
2017-$494.9K—